← All compounds
peptide40 listings
CJC-1295
Growth Hormone Releasing Hormone Analog
Synthetic GHRH analog. Stimulates natural GH release.
GH researchMetabolic studies
/ research index
The research base
Research Maturity
★★★★☆
4/5 — Volume of studies
Evidence Strength
★★★★☆
4/5 — Quality of evidence
60+ studies. Solid evidence for GH stimulation. Works synergistically with GHRP compounds.
/ mechanism of action
How it works
GHRH receptor agonist. Stimulates anterior pituitary to release GH.
/ research dosing
Common research protocols
Range
No DAC: 100-300 mcg/dose, daily; DAC: 1-2 mg/week
Frequency
No DAC: daily before bed (5 on/2 off); DAC: weekly
Route
Subcutaneous on empty stomach
Cycle
8-12 weeks on, 8 weeks off
Research notes
CJC-1295 (no DAC, also called Mod-GRF 1-29) has 30-min half-life — daily dosing maintains pulsatile GH release. CJC-1295 DAC has 6-8 day half-life — sustained but less physiological. No DAC version typically preferred for research due to better pulse pattern. Often stacked with Ipamorelin 1:1.
References
FOR RESEARCH USE ONLY. Doses listed are compiled from published research literature, FDA-approved drug labels, and well-documented research community practice. Not medical advice.
/ standalone use
As a solo compound
Effective standalone for GH research.
Common pairings
/ side effects
What to know
Minimal. Occasional flushing at injection site.
/ timeline
Realistic expectations
GH elevation 1-2 weeks
/ recommendation
Where to buy CJC-1295
🏆Our pick for CJC-1295
Ascension Peptides
10mg · USA · Card / Crypto / Zelle
- ✓Third-party tested (Janoshik)
- ✓COAs provided — Per-batch core, quarterly bonus
- ✓Highest verification tier in stock
- ✓4.8★ community rating
Also solid
/ all listings
Full index, price per mg
Supplier
Trust Score
Size
Price
$/mg
Stock
Buy
FOR RESEARCH USE ONLY. CJC-1295 is intended for laboratory research and not for human consumption.